Publicaciones en colaboración con investigadores/as de Universidad de Zaragoza (24)

2024

  1. Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)

    Helicobacter, Vol. 29, Núm. 4

  2. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

  3. Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn’s Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn’s Fistula (the PRIME Study)

    Diseases of the Colon and Rectum, Vol. 67, Núm. 7, pp. 960-967

2023

  1. Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations (Scientific Reports, (2023), 13, 1, (17235), 10.1038/s41598-023-43287-4)

    Scientific Reports

  2. Comparison of the management of Helicobacter pylori infection between the older and younger European populations

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

    Frontiers in Medicine, Vol. 9

2018

  1. Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox

    United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629

  2. Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding

    Gastroenterologia y Hepatologia

2017

  1. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

    Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862

2016

  1. Endoscopist characteristics that influence the quality of colonoscopy

    Endoscopy, Vol. 48, Núm. 3, pp. 241-247

  2. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

    Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551

2015

  1. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease

    International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373

  2. Reply

    Clinical Gastroenterology and Hepatology

  3. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants

    Clinical Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 906-912.e2

2014

  1. Effect of oral anticoagulants on the outcome of faecal immunochemical test

    British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337

  2. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata

    Scandinavian Journal of Gastroenterology, Vol. 49, Núm. 10, pp. 1181-1190

  3. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

    Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997

2013

  1. Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test

    Mayo Clinic Proceedings

  2. Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: Comparison of event rates in routine clinical practice and a clinical trial

    Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 3, pp. 285-294

  3. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies

    Gastrointestinal Endoscopy, Vol. 77, Núm. 3